Literature DB >> 16789154

Simian virus 40 DNA segment of the adenovirus 7-simian virus 40 hybrid, e46, and its transcription during permissive infection of monkey kidney cells.

P Lebowitz1, G Khoury.   

Abstract

Nucleic acid hybridization methodology has been used to investigate the span of the simian virus 40 (SV40) DNA segment in the adenovirus 7-SV40 hybrid, E46(+), and the extent of its transcription in lytically infected monkey kidney cells. The SV40 segment of E46(+) comprises approximately 62% of the SV40 genome; it originates in the proximal region of Hin-G (the G fragment derived by cleavage of intact SV40 DNA with Haemophilus influenzae restriction endonuclease), extends sequentially through approximately 80% of this fragment, all of fragments Hin-B, -I, -H, and -A, and terminates approximately 70% of the distance through Hin-C. During E46(+) lytic infection of permissive cells, the vast majority of stable cytoplasmic SV40-specific RNA is transcribed from the minus (E) strand of the fragments Hin-A, -H, -I, and -B, comprising the early template region. Transcripts of the minus strand of the Hin-G and -C fragments are detected in much lower concentrations, especially in the total lytic cellular RNA, whereas RNA complementary to the plus (L) strand is not detected. The transcriptional pattern of the SV40 segment within E46(+) is thus very similar to that in a number of transformed cell lines and in some respects to the transcriptional pattern in a series of nondefective adenovirus 2-SV40 hybrid viruses. These results suggest a common transcriptional mechanism for integrated SV40 DNA.

Entities:  

Year:  1975        PMID: 16789154      PMCID: PMC354576     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  A map of simian virus 40 transcription sites expressed in productively infected cells.

Authors:  G Khoury; M A Martin; T N Lee; K J Danna; D Nathans
Journal:  J Mol Biol       Date:  1973-08-05       Impact factor: 5.469

2.  Strand orientation of SV40 transcription in cells infected by non-defective adenovirus 2-SV40 hybrid viruses.

Authors:  G Khoury; A M Lewis; M N Oxman; A S Levine
Journal:  Nat New Biol       Date:  1973-12-19

3.  A quantitative assay for DNA-RNA hybrids with DNA immobilized on a membrane.

Authors:  D Gillespie; S Spiegelman
Journal:  J Mol Biol       Date:  1965-07       Impact factor: 5.469

4.  A restriction enzyme from Hemophilus influenzae. I. Purification and general properties.

Authors:  H O Smith; K W Wilcox
Journal:  J Mol Biol       Date:  1970-07-28       Impact factor: 5.469

5.  RNA production in adenovirus-infected KB cells.

Authors:  J A Rose; P R Reich; S M Weissman
Journal:  Virology       Date:  1965-12       Impact factor: 3.616

6.  A dye-buoyant-density method for the detection and isolation of closed circular duplex DNA: the closed circular DNA in HeLa cells.

Authors:  R Radloff; W Bauer; J Vinograd
Journal:  Proc Natl Acad Sci U S A       Date:  1967-05       Impact factor: 11.205

7.  Mapping of simian virus 40 early functions on the viral chromosome.

Authors:  J F Morrow; P Berg; T J Kelly; A M Lewis
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

8.  Control of simian virus 40 gene expression in adenovirus-simian virus 40 hybrid viruses. Synthesis of hybrid adenovirus 2-simian virus 40 RNA molecules in cells infected with a nondefective adenovirus 2-simian virus 40 hybrid virus.

Authors:  M N Oxman; M J Levin; A M Lewis
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

9.  Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome.

Authors:  T J Kelly; A M Lewis
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

10.  Nucleotide sequences of RNA transcribed in infected cells and by Escherichia coli RNA polymerase from a segment of simian virus 40 DNA.

Authors:  R Dhar; S Zain; S M Weissman; J Pan; K Subramanian
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.